Rapid Drug Susceptibility Testing for Tuberculosis Using Raman-Deuterium Isotope Probing
By
Yizhi Song
Summary
This article presents a novel method for rapid drug susceptibility testing (DST) of Mycobacterium tuberculosis using Raman-deuterium isotope probing. It addresses the critical global health challenge of drug-resistant tuberculosis, which caused 1.25 million deaths in 2023. The research describes a phenotypic approach that significantly reduces the time needed to determine drug resistance profiles compared to conventional culture-based methods, potentially enabling faster, more targeted treatment for TB patients, particularly those with multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains.
Source
Key quotes
· 3 pulledTuberculosis (TB), caused by M. tuberculosis (MTB), remains a leading cause of infectious disease mortality worldwide.
According to the 2024 World Health Organization (WHO) Global Tuberculosis Report, an estimated 10.8 million incident TB cases (95% UI: 10.1–11.7 million) were reported in 2023, resulting in 1.25 million TB-attributable deaths (95% UI: 1.13–1.37 million).
The global rise in drug-resistant TB (DR-TB), particularly multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains, poses a major threat to control efforts.
You might also wanna read

Study finds persistently high mortality in drug-resistant Gram-negative infections despite new antibiotics
This retrospective cohort study examines whether mortality rates among patients with difficult-to-treat resistant (DTR) Gram-negative infect

Deep learning model identifies novel antibiotic compounds effective against drug-resistant gonorrhea
This article describes a study where researchers developed and validated a deep learning model to discover new antibiotics effective against
Fighting the world's deadliest infection with PAC-MAN and AI
Global protein-ligand binding affinity profiling via photocatalytic labeling
MIT Develops Noninvasive Glucose Monitoring Device Using Raman Spectroscopy
MIT researchers have developed a noninvasive device using Raman spectroscopy to measure blood glucose levels without finger pricks. The shoe
NMR-based metabolomics and machine learning show promise for non-invasive disease screening in dogs
This study evaluates the use of NMR-based metabolomics combined with machine learning for non-invasive disease screening in dogs, specifical

Comments
Sign in to join the conversation.
No comments yet. Be the first.